Furthermore, vascular calcification and function were unaffected by FGF23 treatment in vitro and ex vivo respectively, thus not supporting direct vascular effects by FGF23 as the cause of vascular pathology in CKD. This evidence concerns the gene FGF23 and chronic kidney disease.